“I had the privilege of attending ASCO GI to present our team’s research, led by Dr. Kyaw Thein! We were honored to have three meta-analyses accepted for presentation and publication in the Journal of Clinical Oncology.

Here are the links to our research for those interested in exploring them further.”

1. Meta-analysis of randomized controlled trials (RCTs) to evaluate the incidence of hemorrhage and venous thromboembolism (VTE) events in patients with gastrointestinal (GI) cancers treated with fruquintinib.

2. Meta-analysis of phase II/III randomized controlled trials (RCTs) to determine the incidence of hypertension and proteinuria in patients with gastrointestinal (GI) cancers treated with fruquintinib.

3. Meta-analysis of phase II/III randomized controlled trials (RCTs) to evaluate the incidence of hand-foot skin reaction (HFSR) or palmar-plantar erythrodysesthesia (PPE) syndrome in patients with gastrointestinal (GI) cancers treated with fruquintinib.

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research